blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2843040

EP2843040 - Cell culture method and utilization of the same [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  03.11.2017
Database last updated on 02.09.2024
FormerRequest for examination was made
Status updated on  02.08.2017
Most recent event   Tooltip03.11.2017Application deemed to be withdrawnpublished on 06.12.2017  [2017/49]
Applicant(s)For all designated states
Chugai Seiyaku Kabushiki Kaisha
5-1, Ukima 5-chome Kita-ku
Tokyo 115-8543 / JP
[2015/10]
Inventor(s)01 / Goto, Susumu
c/o CHUGAI SEIYAKU KABUSHIKI KAISHA
5-1, Ukima 5-chome
Kita-ku
Tokyo 115-8543 / JP
02 / Kishishita, Shohei
c/o CHUGAI SEIYAKU KABUSHIKI KAISHA
5-1, Ukima 5-chome
Kita-ku
Tokyo 115-8543 / JP
03 / Takuma, Shinya
c/o CHUGAI SEIYAKU KABUSHIKI KAISHA
5-1, Ukima 5-chome
Kita-ku
Tokyo 115-8543 / JP
04 / Hirashima, Chikashi
c/o CHUGAI SEIYAKU KABUSHIKI KAISHA
5-1, Ukima 5-chome
Kita-ku
Tokyo 115-8543 / JP
 [2015/10]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [2015/10]Vossius & Partner
Siebertstrasse 3
81675 München / DE
Application number, filing date14189055.826.12.2005
[2015/10]
Priority number, dateJP2005000074705.01.2005         Original published format: JP 2005000747
[2015/10]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2843040
Date:04.03.2015
Language:EN
[2015/10]
Search report(s)(Supplementary) European search report - dispatched on:EP03.02.2015
ClassificationIPC:C12N5/00, C12N5/10, C12P21/02
[2015/10]
CPC:
C12N5/0037 (EP,US); C12N5/0031 (KR); C12N2500/80 (EP,US);
C12N2510/02 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2015/42]
Former [2015/10]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Zellkulturverfahren und Verwendung davon[2015/10]
English:Cell culture method and utilization of the same[2015/10]
French:Procédé de culture de cellules et utilisation de celui-ci[2015/10]
Examination procedure03.09.2015Examination requested  [2015/42]
04.09.2015Amendment by applicant (claims and/or description)
01.07.2017Application deemed to be withdrawn, date of legal effect  [2017/49]
03.08.2017Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2017/49]
Parent application(s)   TooltipEP05819639.5  / EP1835022
Fees paidRenewal fee
13.02.2015Renewal fee patent year 03
13.02.2015Renewal fee patent year 04
13.02.2015Renewal fee patent year 05
13.02.2015Renewal fee patent year 06
13.02.2015Renewal fee patent year 07
13.02.2015Renewal fee patent year 08
13.02.2015Renewal fee patent year 09
13.02.2015Renewal fee patent year 10
22.12.2015Renewal fee patent year 11
Penalty fee
Additional fee for renewal fee
31.12.201612   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO9523212  (SEA RUN HOLDINGS INC [US]) [A] 1-16 * the whole document *;
 [Y]EP1085083  (CHUGAI PHARMACEUTICAL CO LTD [JP]) [Y] 1-16 * the whole document *;
 [AD]JP2003334068  (CHUGAI PHARMACEUTICAL CO LTD, et al) [AD] 1-16 * abstract *;
 [XDP]WO2005005636  (CHUGAI PHARMACEUTICAL CO LTD [JP], et al) [XDP] 1-16 * abstract *;
 [E]EP1652925  (CHUGAI PHARMACEUTICAL CO LTD [JP], et al) [E] 1-16 * the whole document *;
 [X]  - PAGE WILLIAM J ET AL, "Growth of Azotobacter vinelandii UWD in fish peptone medium and simplified extraction of poly-beta-hydroxybutyrate", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, (1993), vol. 59, no. 12, ISSN 0099-2240, pages 4236 - 4244, XP002543473 [X] 1-4 * the whole document * * page 4238, column R, paragraph 2 - page 4239, column R, paragraph 2 * * table 1 *
 [A]  - FRAHM B ET AL, "Improvement of a mammalian cell culture process by adaptive, model-based dialysis fed-batch cultivation and suppression of apoptosis", BIOPROCESS AND BIOSYSTEMS ENGINEERING, SPRINGER, DE, (20031101), vol. 26, no. 1, doi:10.1007/S00449-003-0335-Z, ISSN 1615-7591, pages 1 - 10, XP002997132 [A] 1-16 * the whole document *

DOI:   http://dx.doi.org/10.1007/s00449-003-0335-z
 [A]  - A.-P. ZENG ET AL, "Mathematical modeling and analysis of glucose and glutamine utilization and regulation in cultures of continuous mammalian cells", BIOTECHNOLOGY AND BIOENGINEERING, (19950805), vol. 47, no. 3, doi:10.1002/bit.260470308, ISSN 0006-3592, pages 334 - 346, XP055005401 [A] 1-16 * the whole document *

DOI:   http://dx.doi.org/10.1002/bit.260470308
 [Y]  - XUEJUN GU ET AL, "Influence of Primatone RL supplementation on sialylation of recombinant human interferon-[gamma] produced by Chinese hamster ovary cell culture using serum-free media", BIOTECHNOLOGY AND BIOENGINEERING, (19971120), vol. 56, no. 4, doi:10.1002/(SICI)1097-0290(19971120)56:4<353::AID-BIT1>3.0.CO;2-N, ISSN 0006-3592, pages 353 - 360, XP055005426 [Y] 1-16 * the whole document *

DOI:   http://dx.doi.org/10.1002/(SICI)1097-0290(19971120)56:4<353::AID-BIT1>3.0.CO;2-N
by applicantWO9219759
 JPH0899902
 WO9963058
 JP2003334068
 JP2005000747
 WO2005005636
 WO2005056604
    - Introduction to Antibody Engineering, CHIJIN SHO KAN PUBLISHING COMPANY, pages 102 - 104
    - Affinity Chromatography Principles & Methods, AMERSHAM PHARMACIA BIOTECH, pages 56 - 60
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.